| ¿ Es el aprocitentan, un antagonista dual de la endotelina, eficaz para mejorar el control de la tensión arterial en los pacientes con hipertensión resistente? MP Schlaich, M Bellet, P Danaietash, JM Flack | | 2023 |
| [LB. 02.04] EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY WITH FOLLOW-UP DATA OF 3 YEARS C Ott, F Mahfoud, G Mancia, K Narkiewicz, LM Ruilope, MP Schlaich, ... Journal of Hypertension 35, e49, 2017 | | 2017 |
| [OP. 4B. 03] BI-DIRECTIONAL INTERACTION BETWEEN THE SYMPATHETIC NERVOUS SYSTEM AND SGLT-2 REGULATION M Schlaich, C Rudnicka, L Herat, J Hricova, R Elliott, V Matthews Journal of Hypertension 35, e38, 2017 | | 2017 |
| [OP. 5A. 06] RENAL DENERVATION PREVENTS PROGRESSION OF HYPERTENSION AND CHANGES TO BAROREFLEX IN A RABBIT MODEL OF CHRONIC KIDNEY DISEASE G Head, Y Sata, S Burke, K Denton, G Lambert, M Schlaich Journal of Hypertension 35, e42, 2017 | | 2017 |
| [OP. 7A. 01] THE GLOBAL SYMPLICITY REGISTRY: SAFETY AND EFFICACY REPORT M Schlaich, M Boehm, G Mancia, R Schmieder, F Mahfoud Journal of Hypertension 35, e63, 2017 | | 2017 |
| [OP. 7A. 06] FIRST-IN-HUMAN EVALUATION OF A TRANSVENOUS CAROTID BODY ABLATION DEVICE TO TREAT PATIENTS WITH RESISTANT HYPERTENSION M Schlaich, H Sievert, V Reddy, D Hering, C Schultz, S Shetty, S Worthley, ... Journal of Hypertension 35, e64, 2017 | 4 | 2017 |
| [OP. 7A. 08] A POLYMORPHISM IN THE NORADRENALINE TRANSPORTER GENE IS ASSOCIATED WITH INCREASED BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION N Eikelis, D Hering, P Marusic, A Walton, E Lambert, M Esler, M Schlaich, ... Journal of Hypertension 35, e65, 2017 | | 2017 |
| [OP. 7A. 11] CHROMOGRANIN A AS A PREDICTIVE MARKER OF SUCCESSFUL RENAL DENERVATION NB Chamoux, N Eikelis, B Pereira, D Hering, P Marusic, E Lambert, ... Journal of Hypertension 35, e66, 2017 | | 2017 |
| [OP. 7D. 10] THE EFFECT OF RENAL DENERVATION ON ADIPOKINES IN PATIENTS WITH RESISTANT HYPERTENSION N Eikelis, D Hering, P Marusic, A Walton, E Lambert, H Krum, G Lambert, ... Journal of Hypertension 34, e97, 2016 | 1 | 2016 |
| [PP. 05.32] PROFOUND SYMPATHETIC NERVOUS SYSTEM ACTIVATION IN PATIENTS WTH RESISTANT HYPERTENSION M Schlaich, D Hering, G Lambert, N Eikelis, S Philipps, E Lambert, Y Sata, ... Journal of Hypertension 35, e127, 2017 | 1 | 2017 |
| [PP. 18.21] MUSCLE SYMPATHETIC NERVE ACTIVITY IS ASSOCIATED WITH ELEMENTS OF THE PLASMA LIPIDOMIC PROFILE IN YOUNG ASIAN ADULTS AT LOWER LEVELS OF OBESITY N Eikelis, E Lambert, S Phillips, C Sari, J Weir, K Huynh, J Dixon, ... Journal of Hypertension 35, e237, 2017 | | 2017 |
| [PP. 18.22] EFFECTS OF MOXONIDINE AND LOW CALORIE DIET IN YOUNG OVERWEIGHT MALES E Lambert, C Sari, G Head, M Grima, N Eikelis, N Straznicky, MP Schlaich, ... Journal of Hypertension 35, e237, 2017 | | 2017 |
| [PP. 21.11] NOVEL IDENTIFICATION OF NOCTURNAL HYPERTENSION IMPROVES PREDICTION OF CARDIOVASCULAR DEATH IN A GENERAL POPULATION G Head, Y Sata, Y Imai, T Ohkubo, M Kikuya, M Schlaich Journal of Hypertension 35, e272, 2017 | | 2017 |
| 11 Monocyte activation & novel biomarker sub-study of LoDoCo-MI T Hennessy, V Matthews, R Kurup, C Rudnicka, M Schlaich, S Patel, ... Heart 105 (Suppl 7), A8-A10, 2019 | | 2019 |
| 1166 A/C polymorphism of the angiotensin (ANG) II type 1 receptor (AT1) and the response to infused ANG II. KF Hilgers, MRW Langenfeld, M Schlaich, R Veelken, RE Schmieder JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 8, A1455-A1455, 1997 | | 1997 |
| 1166 A/C polymorphism of the angiotensin II type 1 receptor (AT1) gene and the response to infused angiotensin (ANG) II KF Hilgers, MRW Langenfeld, M Schlaich, R Veelken, RE Schmieder JOURNAL OF HYPERTENSION 16, S53-S53, 1998 | 1 | 1998 |
| 1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II KF Hilgers, MRW Langenfeld, M Schlaich, R Veelken, RE Schmieder Circulation 100 (13), 1394-1399, 1999 | 84 | 1999 |
| 1199 Reduction in blood pressure following renal denervation for patients with differing baseline cardiovascular risk F Mahfoud, G Mancia, R Schmieder, K Narkiewicz, L Ruilope, M Schlaich, ... European Heart Journal 40 (Supplement_1), ehz748. 0029, 2019 | | 2019 |
| 1416 Transvenous carotid body ablation for resistant hypertension: main results of a multicentre safety and proof-of-principle cohort study M Schlaich, C Schultz, S Shetty, D Hering, S Worthley, S Delacroix, ... European Heart Journal 39 (suppl_1), ehy565. 1416, 2018 | 2 | 2018 |
| 155 Role of nerve firing, norepinephrine reuptake and angiotensin neuromodulation for sympathetic nervous augmentation in essential hypertension M Schlaich, E Lambert, D Kaye, J Hastings, G Lambert, MD Esler European Heart Journal 5 (24), 15, 2003 | | 2003 |
Murray EslerSenior Director Baker IDI Heart and Diabetes Institute在 bakeridi.edu.au 的电子邮件经过验证
